Penny Bemus
Senior Vice President, Commercial Strategy
Expertise:
Penny’s extensive background and expertise in finance, corporate development, business development, marketing, and experience with startups informs the work she does helping life science companies optimize support services and distribution models to commercialize new therapies for rare and orphan disease patient populations.
Over the course of her career, she has supported the development and launch of innovative patient-centric business models that have led to higher adherence and improved economic value.
Penny holds a BSBA from the Ohio State University, an MBA from Washington University in St. Louis, and a JD from St. Louis University.
She is an active member of the Healthcare Businesswomen’s Association.
Events with Penny Bemus
Articles by Penny Bemus
“Nothing changes if nothing changes.”
Patients deserve quick and easy access to care. That’s why EVERSANA DIRECT goes beyond the “bare minimum” of DTP solutions, delivering a seamless end‑to‑end patient experience—from patient identification through prescription refills. Two-thirds of drug launches fall short of revenue goals, but a new approach is changing the trend. Today’s most successful brands are rethinking the traditional playbook by pairing integrated commercialization models with direct-to-patient (DTP) […]
“Nothing changes if nothing changes.”
“Nothing changes if nothing changes.” Why an integrated commercialization platform with the amplified power of a direct-to-patient (DTP) channel is no longer an option. It’s a must. Two-thirds of drug launches fall short of revenue goals, but a new approach is changing the trend. Today’s most successful brands are rethinking the traditional playbook by pairing […]